Stockscreener 앱 받기
0.3342
0.86%
-0.0029
시간 외 거래:
.33
-0.0042
-1.26%
전일 마감가:
$0.3371
열려 있는:
$0.3372
하루 거래량:
3.52M
Relative Volume:
0.88
시가총액:
$193.05M
수익:
$22.39M
순이익/손실:
$-60.39M
주가수익비율:
-1.8383
EPS:
-0.1818
순현금흐름:
$-70.51M
1주 성능:
-4.38%
1개월 성능:
-2.57%
6개월 성능:
-33.81%
1년 성능:
-37.66%
1일 변동 폭
$0.33
$0.342
1주일 범위
$0.33
$0.369
52주 변동 폭
$0.32
$0.75
센서닉스 홀딩스 Stock (SENS) Company Profile
명칭
Senseonics Holdings Inc
전화
301-515-7260
주소
20451 Seneca Meadows Parkway, Germantown, MD
센서닉스 홀딩스 Stock (SENS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-08-19 | 개시 | H.C. Wainwright | Buy |
| 2021-04-01 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-03-05 | 다운그레이드 | Raymond James | Mkt Perform → Underperform |
| 2021-01-21 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-01-20 | 다운그레이드 | Craig Hallum | Hold → Sell |
| 2020-08-11 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-08-11 | 업그레이드 | Craig Hallum | Sell → Hold |
| 2020-03-13 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-03-13 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-11-13 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2019-11-13 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2019-10-23 | 개시 | Stifel | Buy |
| 2019-07-05 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-01-29 | 개시 | Piper Jaffray | Neutral |
| 2018-08-24 | 개시 | Dougherty & Company | Buy |
모두보기
센서닉스 홀딩스 주식(SENS)의 최신 뉴스
What Did We Find About Insider Trading At Senseonics Holdings Inc (AMEX: SENS)? - Stocks Register
Senseonics (NYSE:SENS) Now Covered by Analysts at StockNews.com - MarketBeat
Senseonics stock dips on $16M securities offering - MSN
Senseonics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits - Quantisnow
Senseonics Holdings Expands Equity and Financial Strategy - TipRanks
Senseonics announces $16 million stock and warrant sale By Investing.com - Investing.com Canada
Senseonics announces $16 million stock and warrant sale - Investing.com
Senseonics Holdings, Inc. Announces $16 Million Registered Direct Offering - GlobeNewswire
SENSSenseonics Holdings, Inc. Latest Stock News & Market Updates - StockTitan
Senseonics Holdings, Inc. Schedules Third Quarter 2024 - GlobeNewswire
Senseonics Holdings, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for November 7, 2024 at 4:30 P.M. Eastern Time - Quantisnow
Senseonics Holdings (STU:6L6) 3-Year Revenue Growth Rate : 21.00% (As of Jun. 2024) - GuruFocus.com
Senseonics Holdings (STU:6L6) Revenue per Share : €0.04 (TTM As of Jun. 2024) - GuruFocus.com
Senseonics Holdings (STU:6L6) Cost of Goods Sold : €19.56 Mil (TTM As of Jun. 2024) - GuruFocus.com
Senseonics Holdings (STU:6L6) Forward Dividend Yield % : 0.00% (As of Oct. 23, 2024) - GuruFocus.com
Senseonics (NYSE:SENS) Earns Sell Rating from Analysts at StockNews.com - MarketBeat
Senseonics to Host Virtual KOL Event on Eversense 365: FDA - GlobeNewswire
Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM System - StockTitan
The time has not yet come to remove your chips from the table: Senseonics Holdings Inc (SENS) - SETE News
Investing in Senseonics Holdings Inc (SENS) Is Getting More Attractive - Knox Daily
StockNews.com Begins Coverage on Senseonics (NYSE:SENS) - MarketBeat
Analyzing the Impact of Earnings Reports on Senseonics Holdings Inc Inc. (SENS) Price Performance - The InvestChronicle
Financial Snapshot: Analyzing Senseonics Holdings Inc (SENS)’s Key Ratio Metrics - The Dwinnex
Senseonics Holdings Inc (SENS) requires closer examination - US Post News
Eversense 365 CGM system launches for year-long diabetes monitoring By Investing.com - Investing.com Australia
Eversense 365 CGM system launches for year-long diabetes monitoring - Investing.com India
Mercy Places First Commercial Eversense 365: The World’s First and Only 365-Day Continuous Glucose Monitor - GlobeNewswire
Mercy Places First Commercial Eversense 365: The World's First and Only 365-Day Continuous Glucose Monitor - PR Newswire
SENS’s latest rating updates from top analysts. - Knox Daily
Stock Performance Spotlight: Senseonics Holdings Inc (SENS) Ends the Day at 0.34, Up by 3.00 - The Dwinnex
StockNews.com Initiates Coverage on Senseonics (NYSE:SENS) - MarketBeat
Eversense 365 Launches in the US: One Year. One CGM. – Company Announcement - Financial Times
Can you now get a good deal on Senseonics Holdings Inc’s shares? - US Post News
Senseonics Stock Down Despite New FDA Approval for Eversense 365 - MSN
State of New Jersey Common Pension Fund D Sells 27,371 Shares of Sensata Technologies Holding plc (NYSE:ST) - Defense World
Sensata Technologies (NYSE:ST) Releases Q3 2024 Earnings Guidance - Defense World
SenesTech stock hits 52-week low at $2.4 amid sharp decline - Investing.com
Senseonics Eversense 365 glucose monitor cleared in the U.S. - MSN
Eversense 365, a 1-Year CGM, Cleared by the FDA - diaTribe Foundation
FDA Clears First 1-Year CGM for Diabetes - Drug Topics
Investing in Senseonics Holdings Inc (SENS): What You Must Know - Knox Daily
FDA Clearance Announcement Sends Small Cap Soaring - MSN
Senseonics and Ascensia announce FDA approval for one-year CGM system - Medical Device Network
Market Highlights: Senseonics Holdings Inc (SENS) Ends on a High Note at 0.44 - The Dwinnex
Stifel maintains Buy rating on Senseonics, cites FDA approval By Investing.com - Investing.com Canada
FDA approves Eversense 365 as year-long diabetes monitor - Investing.com
FDA Clears Eversense® 365: The World’s First One-Year CGM System - HIT Consultant
FDA clears Senseonic’s Eversense one-year implantable CGM - BioWorld Online
센서닉스 홀딩스 (SENS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.47%
1.00%
자본화:
|
볼륨(24시간):